Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 470

Similar articles for PubMed (Select 21446776)

1.

Are all statins the same? Focus on the efficacy and tolerability of pitavastatin.

da Silva PM.

Am J Cardiovasc Drugs. 2011;11(2):93-107. doi: 10.2165/11591190-000000000-00000. Review.

PMID:
21446776
2.
3.

Pitavastatin: a review of its use in the management of hypercholesterolaemia or mixed dyslipidaemia.

Duggan ST.

Drugs. 2012 Mar 5;72(4):565-84. doi: 10.2165/11207180-000000000-00000. Review.

PMID:
22356292
4.

Pitavastatin: novel effects on lipid parameters.

Chapman MJ.

Atheroscler Suppl. 2011 Nov;12(3):277-84. doi: 10.1016/S1567-5688(11)70887-X. Review.

PMID:
22152282
5.

Pitavastatin in cardiometabolic disease: therapeutic profile.

Masana L.

Cardiovasc Diabetol. 2013;12 Suppl 1:S2. doi: 10.1186/1475-2840-12-S1-S2. Epub 2013 May 30. Review.

6.

Comparison of the efficacy and tolerability of pitavastatin and atorvastatin: an 8-week, multicenter, randomized, open-label, dose-titration study in Korean patients with hypercholesterolemia.

Lee SH, Chung N, Kwan J, Kim DI, Kim WH, Kim CJ, Kim HS, Park SH, Seo HS, Shin DG, Shin YW, Shim WJ, Ahn TH, Ho Yun K, Yoon MH, Cha KS, Choi SW, Han SW, Hyon MS.

Clin Ther. 2007 Nov;29(11):2365-73.

PMID:
18158077
7.

Pitavastatin: clinical effects from the LIVES Study.

Teramoto T.

Atheroscler Suppl. 2011 Nov;12(3):285-8. doi: 10.1016/S1567-5688(11)70888-1. Review.

PMID:
22152283
8.

Critical appraisal of the role of pitavastatin in treating dyslipidemias and achieving lipid goals.

Saito Y.

Vasc Health Risk Manag. 2009;5:921-36. Epub 2009 Nov 16. Review.

9.

Pitavastatin: an overview.

Saito Y.

Atheroscler Suppl. 2011 Nov;12(3):271-6. doi: 10.1016/S1567-5688(11)70886-8. Review.

PMID:
22152281
10.

Pitavastatin calcium: clinical review of a new antihyperlipidemic medication.

Yee LL, Wright EA.

Clin Ther. 2011 Aug;33(8):1023-42. doi: 10.1016/j.clinthera.2011.07.011. Epub 2011 Aug 4. Review.

PMID:
21816477
11.
12.

Distinct effects of pitavastatin and atorvastatin on lipoprotein subclasses in patients with Type 2 diabetes mellitus.

Shimabukuro M, Higa M, Tanaka H, Shimabukuro T, Yamakawa K, Masuzaki H.

Diabet Med. 2011 Jul;28(7):856-64. doi: 10.1111/j.1464-5491.2011.03240.x.

PMID:
21244474
13.

Rosuvastatin: a highly effective new HMG-CoA reductase inhibitor.

Olsson AG, McTaggart F, Raza A.

Cardiovasc Drug Rev. 2002 Winter;20(4):303-28. Review.

PMID:
12481202
14.

Comparative long-term efficacy and tolerability of pitavastatin 4 mg and atorvastatin 20-40 mg in patients with type 2 diabetes mellitus and combined (mixed) dyslipidaemia.

Gumprecht J, Gosho M, Budinski D, Hounslow N.

Diabetes Obes Metab. 2011 Nov;13(11):1047-55. doi: 10.1111/j.1463-1326.2011.01477.x.

PMID:
21812889
15.

Pitavastatin: a new HMG-CoA reductase inhibitor for the treatment of hypercholesterolemia.

Ahmad H, Cheng-Lai A.

Cardiol Rev. 2010 Sep-Oct;18(5):264-7. doi: 10.1097/CRD.0b013e3181ebdb2f. Review.

PMID:
20699675
16.

Searching the place of pitavastatin in the current treatment of patients with dyslipidemia.

Barrios V, Escobar C, Zamorano JL.

Expert Rev Cardiovasc Ther. 2013 Dec;11(12):1597-612. doi: 10.1586/14779072.2013.844546. Review.

PMID:
24215190
17.

Comparison of the efficacy and tolerability of policosanol with atorvastatin in elderly patients with type II hypercholesterolaemia.

Castaño G, Mas R, Fernández L, Illnait J, Mesa M, Alvarez E, Lezcay M.

Drugs Aging. 2003;20(2):153-63.

PMID:
12534315
18.

Pitavastatin: a new HMG-CoA reductase inhibitor.

Wensel TM, Waldrop BA, Wensel B.

Ann Pharmacother. 2010 Mar;44(3):507-14. doi: 10.1345/aph.1M624. Epub 2010 Feb 23. Review.

PMID:
20179258
19.

Medical lipid-regulating therapy: current evidence, ongoing trials and future developments.

Evans M, Roberts A, Davies S, Rees A.

Drugs. 2004;64(11):1181-96. Review.

PMID:
15161326
20.

Effects of simvastatin on the lipid profile and attainment of low-density lipoprotein cholesterol goals when added to thiazolidinedione therapy in patients with type 2 diabetes mellitus: A multicenter, randomized, double-blind, placebo-controlled trial.

Lewin AJ, Kipnes MS, Meneghini LF, Plotkin DJ, Perevozskaya IT, Shah S, Maccubbin DL, Mitchel YB, Tobert JA; Simvastatin/Thiazolidinedione Study Group.

Clin Ther. 2004 Mar;26(3):379-89.

PMID:
15110130
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk